Results per Page:
Better mitochondrial function may prevent muscle wasting in prostate cancer patients
From Dr. Jose M. Garcia, MD, PhD, UW Medicine
TEAD1 splicing controls prostate cancer identity
From Drs. Michael Haffner and Colm Morrissey, Cancer Consortium
Mapping how translational machinery shapes lineage determination in prostate cancer
From the Hsieh Lab, Human Biology Division
A quarter century of lifesaving discoveries in prostate cancer
Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide
Does prostate cancer have a goldilocks mentality when it comes to androgens?
From the Nelson lab, Human Biology and Clinical Research Divisions
New prostate cancer cell lines shed light on CRPC
From the Haffner Lab, Human Biology Division
What's new in prostate cancer: 5 takeaways
‘Many reasons for optimism’ says expert at annual community symposium
Targeted therapies push metastatic prostate cancer in new directions
Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments
Research explains how advanced prostate cancer becomes resistant to androgen-deprivation therapy
Findings suggest androgen production occurs within metastatic prostate tumors